Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Matthew G. Vander Heiden

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6702-4192; OpenAlex author ID A5006842434. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 4)
Trials
0
Grants
1
Labs led
1
Collaborators
103
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers, 1 grant

Papers 14

  1. Pancreatic ductal adenocarcinoma: The Vision of Heracles. Co-author DOI 10.1016/j.ccell.2026.07.014↗
  2. Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting Last author DOI 10.64898/2026.02.27.708635↗
  3. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Co-author DOI 10.1038/s41467-023-40024-3↗
  4. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. Co-author DOI 10.15252/embj.2021110466↗
  5. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Co-author DOI 10.1038/s41467-021-22490-9↗
  6. Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. Last author DOI 10.7554/elife.56782↗
  7. Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance. Co-author DOI 10.1158/0008-5472.can-19-0960↗
  8. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0370↗
  9. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Last author DOI 10.1038/s41586-018-0235-7↗
  10. PKM2 is not required for pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s40170-018-0188-1↗
  11. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Co-author DOI 10.1038/ncomms16031↗
  12. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv409↗
  13. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Co-author DOI 10.1158/0008-5472.can-14-2211↗
  14. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗

Grants 1

  1. FY2026 Lustgarten grant: Matthew Vander Heiden AWARD lustgarten:2026-matthew-vander-heiden-fy2026-lustgarten-grant-matthew-vander-h

Closest collaborators

The 25 strongest of 103 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian Matthew Wolpin · 6 shared papers, 2014–2026 · strength 0.54
  2. Allison N. Lau · 5 shared papers, 2018–2021 · strength 0.46
  3. Yetiş Gültekin · 2 shared papers, 2026 · strength 0.41
  4. Jared R. Mayers · 6 shared papers, 2014–2022 · strength 0.38
  5. Jonathan Andrew Nowak · 2 shared papers, 2023–2026 · strength 0.35
  6. Tyler Jacks · 2 shared papers, 2020–2026 · strength 0.31
  7. Laura V. Danai · 4 shared papers, 2018–2020 · strength 0.30
  8. Evan Chen Lien · 3 shared papers, 2018–2022 · strength 0.26
  9. Ana Babić · 3 shared papers, 2018–2023 · strength 0.26
  10. Michael Hayden Rosenthal · 3 shared papers, 2018–2023 · strength 0.26
  11. Chen Yuan · 4 shared papers, 2014–2023 · strength 0.25
  12. Kimmie Ng · 3 shared papers, 2016–2023 · strength 0.24
  13. William A. Freed-Pastor · 1 shared paper, 2026 · strength 0.22
  14. Natalia I. Khalaf · 2 shared papers, 2019–2023 · strength 0.20
  15. Pilhan Kim · 1 shared paper, 2026 · strength 0.19
  16. Marina Lesina · 1 shared paper, 2026 · strength 0.19
  17. Chiara Falcomatà · 1 shared paper, 2026 · strength 0.19
  18. Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.19
  19. Kıvanç Görgülü · 1 shared paper, 2026 · strength 0.19
  20. Didem Karakaş · 1 shared paper, 2026 · strength 0.19
  21. Matthias M. Gaida · 1 shared paper, 2026 · strength 0.19
  22. Carmen Mota Reyes · 1 shared paper, 2026 · strength 0.19
  23. Marina Pasca di Magliano · 1 shared paper, 2026 · strength 0.19
  24. Roland Rad · 1 shared paper, 2026 · strength 0.19
  25. Laura DeLong Wood · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.